Beratarrechea Andrea, Diez-Canseco Francisco, Irazola Vilma, Miranda Jaime, Ramirez-Zea Manuel, Rubinstein Adolfo
South American Center of Excellence for Cardiovascular Health (CESCAS), Institute for Clinical Effectiveness and Health Policy (IECS).
CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Peru.
Prog Cardiovasc Dis. 2016 May-Jun;58(6):661-73. doi: 10.1016/j.pcad.2016.03.003. Epub 2016 Mar 31.
In Latin America, cardiovascular disease (CVD) mortality rates will increase by an estimated 145% from 1990 to 2020. Several challenges related to social strains, inadequate public health infrastructure, and underfinanced healthcare systems make cardiometabolic conditions and non-communicable diseases (NCDs) difficult to prevent and control. On the other hand, the region has high mobile phone coverage, making mobile health (mHealth) particularly attractive to complement and improve strategies toward prevention and control of these conditions in low- and middle-income countries. In this article, we describe the experiences of three Centers of Excellence for prevention and control of NCDs sponsored by the National Heart, Lung, and Blood Institute with mHealth interventions to address cardiometabolic conditions and other NCDs in Argentina, Guatemala, and Peru. The nine studies described involved the design and implementation of complex interventions targeting providers, patients and the public. The rationale, design of the interventions, and evaluation of processes and outcomes of each of these studies are described, together with barriers and enabling factors associated with their implementation.
在拉丁美洲,从1990年到2020年,心血管疾病(CVD)死亡率预计将增长145%。与社会压力、公共卫生基础设施不足以及医疗保健系统资金不足相关的若干挑战,使得心脏代谢疾病和非传染性疾病(NCD)难以预防和控制。另一方面,该地区手机覆盖率很高,这使得移动健康(mHealth)对于补充和改进中低收入国家预防和控制这些疾病的策略格外具有吸引力。在本文中,我们描述了由美国国立心肺血液研究所资助的三个非传染性疾病预防与控制卓越中心在阿根廷、危地马拉和秘鲁开展移动健康干预措施以应对心脏代谢疾病和其他非传染性疾病的经验。所描述的九项研究涉及针对医疗服务提供者、患者和公众的复杂干预措施的设计与实施。本文介绍了这些研究各自的基本原理、干预措施设计以及过程和结果评估,同时还介绍了与实施相关的障碍和促成因素。